fig5
From: Peritoneal mesothelioma

Figure 5. Serum CA125, hyaluronic acid, and SMRP levels during nivolumab treatment in a recurrent mesothelioma patient.
Figure 5. Serum CA125, hyaluronic acid, and SMRP levels during nivolumab treatment in a recurrent mesothelioma patient.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/